Law firm probes Select Medical board over possible undervaluation in $16.50/share buyout deal

Johnson Fistel, PLLP is investigating whether Select Medical's board breached fiduciary duties in its $16.50 per share sale to a consortium led by company insiders and Welsh, Carson, Anderson & Stowe. The probe questions if the board maximized shareholder value and if minority shareholders are fairly compensated. The deal would take Select Medical private, delisting it from the NYSE, pending shareholder approval. Investors who believe the offer undervalues their shares are encouraged to join the investigation.